|
|
|
Insider
Information: |
Bradsher Neal C |
Relationship: |
10% Owner |
City: |
Union City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
7 |
|
Direct
Shares |
129,185 |
|
Indirect Shares
|
57,363,752 |
|
|
Direct
Value |
$1,186,888 |
|
|
Indirect Value
|
$499,113,789 |
|
|
Total
Shares |
57,492,937 |
|
|
Total
Value |
$500,300,677 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
60
|
50
|
Stock
price went up :
|
44
|
16
|
Stock
price went down : |
16
|
34
|
|
|
|
Gain/Loss Ratio : |
2.8
|
2.8
|
Percentage
Gain/Loss : |
10.9%
|
-929.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Questcor Pharmaceuticals Inc |
QCOR |
Director |
2014-08-14 |
0 |
2014-08-14 |
0 |
Premium* |
|
Lineage Cell Therapeutics Ord Shs |
LCTX |
Director, 10% Owner |
2024-02-06 |
87,628 |
2024-02-06 |
41,666,255 |
Premium* |
|
Comarco Inc |
CMRO |
10% Owner |
2017-09-15 |
15,500 |
2017-09-15 |
0 |
Premium* |
|
STAAR Surgical Co |
STAA |
10% Owner |
2024-05-09 |
25,900 |
2024-05-09 |
10,768,431 |
Premium* |
|
Palomar Medical Technologies Inc |
PMTI |
10% Owner |
2013-06-24 |
0 |
2013-06-24 |
0 |
Premium* |
|
Asterias Biotherapeutics Inc |
AST |
See Remarks Below |
2019-03-08 |
0 |
2019-03-08 |
0 |
Premium* |
|
Oncocyte Corp |
OCX |
10% Owner |
2024-04-11 |
157 |
2024-04-11 |
4,929,066 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
612 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 21 of 25
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-05-16 |
4 |
B |
$5.14 |
$522,430 |
D/D |
101,644 |
10,753,880 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-02-02 |
4 |
B |
$6.42 |
$523,808 |
D/D |
81,599 |
9,731,834 |
2.45 |
- |
|
PMTI |
Palomar Medical Technolog... |
10% Owner |
|
2012-04-26 |
4 |
B |
$8.46 |
$544,280 |
D/D |
64,300 |
2,304,716 |
2.45 |
- |
|
PMTI |
Palomar Medical Technolog... |
10% Owner |
|
2012-04-27 |
4 |
B |
$8.47 |
$619,992 |
D/D |
73,202 |
2,377,918 |
2.45 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2022-03-25 |
4 |
B |
$1.44 |
$678,022 |
D/D |
470,000 |
34,935,485 |
3.92 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2012-08-01 |
4 |
B |
$5.16 |
$688,590 |
D/D |
133,572 |
6,352,603 |
2.45 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2016-01-20 |
4 |
B |
$2.35 |
$705,000 |
D/D |
300,000 |
22,164,396 |
3.92 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2012-07-31 |
4 |
B |
$5.11 |
$711,753 |
D/D |
139,300 |
6,219,031 |
2.45 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-08 |
4 |
B |
$2.44 |
$730,500 |
D/D |
300,000 |
12,122,262 |
3.92 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2007-10-11 |
4 |
B |
$2.95 |
$731,010 |
D/D |
247,800 |
3,889,915 |
2.45 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-05-16 |
4 |
B |
$2.45 |
$735,000 |
D/D |
300,000 |
12,422,262 |
2.39 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2013-03-28 |
4 |
B |
$3.81 |
$762,000 |
D/D |
200,000 |
8,822,220 |
3.92 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2014-10-31 |
4 |
B |
$9.32 |
$777,854 |
D/D |
83,441 |
6,970,536 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2015-09-28 |
4 |
B |
$7.07 |
$783,095 |
D/D |
110,724 |
8,558,838 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2016-05-12 |
4 |
B |
$5.65 |
$813,463 |
D/D |
143,935 |
10,561,605 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2007-11-27 |
4 |
B |
$2.75 |
$834,900 |
D/D |
303,600 |
4,324,188 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2023-09-05 |
4 |
B |
$41.87 |
$843,455 |
D/D |
20,144 |
8,803,226 |
2.45 |
% |
|
PMTI |
Palomar Medical Technolog... |
10% Owner |
|
2011-12-20 |
4 |
B |
$8.50 |
$850,000 |
D/D |
100,000 |
2,190,416 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2015-08-24 |
4 |
B |
$7.20 |
$883,008 |
D/D |
122,577 |
8,290,959 |
2.45 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2021-02-11 |
4 |
S |
$124.51 |
$922,868 |
D/D |
(7,412) |
9,566,341 |
0 |
% |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2021-02-10 |
4 |
S |
$124.90 |
$972,846 |
D/D |
(7,789) |
9,573,753 |
0 |
% |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2014-07-22 |
4 |
B |
$2.65 |
$980,500 |
D/D |
370,000 |
13,792,262 |
3.92 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2007-06-21 |
4 |
B |
$4.10 |
$988,100 |
D/D |
241,000 |
3,219,788 |
2.45 |
- |
|
LCTX |
Lineage Cell Therapeutics... |
Director |
|
2012-11-15 |
4 |
B |
$2.90 |
$1,000,001 |
D/D |
344,828 |
8,622,220 |
3.92 |
- |
|
STAA |
STAAR Surgical Co |
10% Owner |
|
2015-09-25 |
4 |
B |
$7.07 |
$1,002,039 |
D/D |
141,651 |
8,448,114 |
2.45 |
- |
|
612 Records found
|
|
Page 21 of 25 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|